Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humacyte's CTEV for CABG in Coronary Artery Disease
NCT07730528Phase 2Not yet recruiting
- Sponsor
- Humacyte
- Start
- Sep 2026
- Primary completion
- Sep 2030
01
Overview
A Phase 2 trial of coronary tissue engineered vessel in coronary artery disease (CAD), sponsored by Humacyte. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
coronary tissue engineered vessel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07730528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07730528.